Description

Olimab 60mg Injection (Denosumab)

Olimab 60mg Injection contains Denosumab 60mg, GENERIC PROLIA a monoclonal antibody used for the treatment of osteoporosis and bone loss disorders in adults. It is commonly prescribed for postmenopausal women with osteoporosis, men at high risk of fractures, and patients experiencing bone loss associated with hormone-related therapies. Denosumab works by targeting RANKL, a protein responsible for bone resorption, helping strengthen bones and reduce fracture risk.

Osteoporosis causes bones to become weak and brittle, increasing the likelihood of fractures even after minor falls or injuries. By reducing osteoclast activity and slowing bone breakdown, Olimab helps improve bone mineral density and supports long-term skeletal health.

Unlike daily tablets, Olimab is administered as a convenient subcutaneous injection, typically once every six months under medical supervision. This dosing schedule makes it a preferred option for many patients requiring long-term osteoporosis treatment.

Benefits of Olimab 60mg Injection

• Helps treat osteoporosis in postmenopausal women
• Supports osteoporosis treatment in men at increased fracture risk
• Increases bone mineral density
• Reduces bone resorption
• Helps lower fracture risk
• Long-acting treatment with twice-yearly administration
• Supports bone health during hormone-related therapies
• Convenient alternative to daily osteoporosis medications
• May help improve long-term skeletal strength and stability

Who May Use Olimab?

Olimab may be prescribed for:

• Postmenopausal osteoporosis
• Osteoporosis in men
• Bone loss associated with hormone therapy
• Patients at high risk of fractures
• Individuals requiring long-term bone density management

How Olimab Works

Denosumab is a RANK Ligand (RANKL) inhibitor. It blocks the activity of RANKL, a protein that promotes the formation and survival of osteoclasts, the cells responsible for bone breakdown. By reducing osteoclast activity, Olimab decreases bone resorption and helps increase bone density.

Administration

Olimab 60mg Injection is administered by a healthcare professional as a subcutaneous injection, usually in the upper arm, thigh, or abdomen. The standard osteoporosis dose is typically given once every six months. Treatment schedules should always follow physician recommendations.

Possible Side Effects

Some patients may experience:

• Back pain
• Joint pain
• Musculoskeletal pain
• Rash
• Constipation
• Headache
• Urinary tract infections
• Nerve pain
• Elevated cholesterol levels

Patients should remain under regular medical supervision during treatment.

Storage

• Store refrigerated between 2°C and 8°C
• Do not freeze
• Protect from direct light
• Keep out of reach of children

Worldwide Availability

Milan Medicals supplies Olimab 60mg Injection for eligible international customers seeking Denosumab treatment for osteoporosis and bone health management. Worldwide shipping options are available for destinations including the USA, UK, UAE, Canada, Australia, New Zealand, Germany, France, and other countries.